Vulnerability · Published Sep 19, 2022 · Assigned by mitre
CVE-2022-38351
High 8.8
In plain English
A high-severity privilege mismanagement in the affected software. Proof-of-concept exploit code is public. The chance it is exploited in the next 30 days is estimated at 1.1% (higher than 66% of all known vulnerabilities).
Severity (CVSS 3.1)8.8High
Exploit odds (30 days)1.1%top 33.9% of all CVEs
Exploited in the wildNo reportsCISA SSVC: poc
Attack toolingNoneno public tooling known
Official description
A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.
Affected products (as reported)
Weakness: CWE-269 · Vector: CVSS:3.1/AC:L/AV:N/A:H/C:H/I:H/PR:L/S:U/UI:N